What the NUPLAZID TV commercial - Living With Parkinsons is about.
Title: NUPLAZID TV Spot, "Living With Parkinson's"
Living with Parkinson's can be an everyday struggle. The physical and emotional toll it takes on individuals and their loved ones is undeniable.
With NUPLAZID, you can regain control of your life. It's time to take charge and rediscover the moments that matter most.
NUPLAZID is more than just a medication. It's a tool that empowers individuals with Parkinson's to find strength, embrace life, and seize each day.
If you or a loved one are living with Parkinson's disease psychosis, talk to your healthcare provider about NUPLAZID. Reclaim your life and live it to the fullest.
[Disclaimer]The commercial ends with the required medical disclaimer: "NUPLAZID may cause side effects. Consult your doctor for proper usage and precautions."
Note: The above description is a fictional portrayal of a potential TV spot for NUPLAZID. The actual content and marketing strategy of any TV spot may differ. This piece is solely an imaginative creation and not a reflection of real advertising.
NUPLAZID TV commercial - Living With Parkinsons produced for
NUPLAZID
was first shown on television on October 13, 2021.
Frequently Asked Questions about nuplazid tv spot, 'living with parkinson's'
Phase 3 DMT trials completing in 2023:
Buntanetap: Reduces the production of alpha-synuclein with the goal of improving motor symptoms of Parkinson's.
The cost for Nuplazid oral capsule 34 mg is around $5,269 for a supply of 30 capsules, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
SAPS-PD responder analysis
13.7% of NUPLAZID-treated patients experienced complete resolution of symptoms (SAPS-PD score reduced to 0 from baseline) vs 1.1% for placebo.
Learn more about pimavanserin oral . This is a brand name drug and a generic may be available. You can buy Nuplazid at the discounted price of $4,985.02 by using the WebMDRx coupon. Even if this drug is covered by Medicare or your insurance, we recommend you compare prices.
Stem cell therapy may benefit Parkinson's Disease by replacing and repairing damaged dopamine-producing nerve cells within the brain.
January 13, 2023
Another new medication for Parkinson's may soon be on its way to the U.S. Food and Drug Administration (FDA) for possible approval. Neuroderm recently announced positive results from its Phase III trial on ND0612, a liquid levodopa/carbidopa.
100% 100% of Medicare Part D plans cover NUPLAZID®. For patients with government insurance such as Medicare, Medicaid, and other government programs, we can help navigate coverage and identify important financial support options.
NUPLAZID is not approved for the treatment of patients with dementia who experience psychosis unless their hallucinations and delusions are related to Parkinson's disease.
HOW DO I TAKE NUPLAZID? The recommended dose of NUPLAZID is one 34 mg capsule, once daily by mouth, with or without food, taken around the same time every day, or as prescribed by your healthcare provider.
You shouldn't stop taking Nuplazid without first talking with your doctor. This is because if you stop taking Nuplazid, your symptoms of Parkinson's disease psychosis may return.
NUPLAZID® (pimavanserin) is the first and only prescription medication approved by the U.S. Food and Drug Administration (FDA) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis (PDP).
A team at UConn Health has discovered a regulator compound that may help development of therapeutic compounds for the brain disease. Other news is on cancer research and non-opioid pain therapies.
